Navigation Links
Halozyme Therapeutics Reports 2008 First Quarter Financial Results
Date:5/8/2008

sales 37,190 76,228

Research and development 8,444,191 2,829,364

Selling, general and administrative 4,157,603 1,985,034

Total Operating Expenses 12,638,984 4,890,626

LOSS FROM OPERATIONS (10,833,466) (4,080,411)

Interest income 879,469 723,107

NET LOSS $(9,953,997) $(3,357,304)

Basic and diluted net loss per share $(0.13) $(0.05)

Shares used in computing net loss per share,

basic and diluted 78,300,319 69,984,931

HALOZYME THERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

AS OF MARCH 31, 2008 AND DECEMBER 31, 2007

March 31, December 31,

2008 2007

(unaudited)

ASSETS:

Cash and cash equivalents $92,558,408 $97,679,085

Accounts receivable 1,130,384 779,825

Inventory 679,083 703,468

Prepaid expenses and other assets 2,252,861 2,014,680

Total current assets 96,620,736 101,177,058

Property and equipment, net 2,251,099 2,283,316

Total Assets $98,871,835 $103,460,374

LIABILITIES AND STOCKHOLDERS' EQUITY:

Accounts payable $3,398,587 $3,055,637

Accrued expenses 2,942,071 2,502,259

Deferred revenue 3,261,983 3,306,225

Total current
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
2. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
3. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
4. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
5. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
6. Halozyme Therapeutics Amends Stockholder Rights Plan
7. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
8. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
9. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
10. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
11. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Ga. , Aug. 26, 2014  ViveBio, ... biological sample collection, stabilization and transportation, announced today ... Laboratory Procurement Services, LLC (LPS) of ... of products in the United States ... new class of ambient temperature dried biological specimen ...
(Date:8/26/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
(Date:8/26/2014)... WASHINGTON , Aug. 26, 2014 ... Next Generation Dx Summit; Moving Assays to ... "Targeted Detection and Monitoring of Cell Free Tumor ... the analytical component of its Precision Cancer Monitoring ... high clinical sensitivity for the detection of tumor ...
(Date:8/26/2014)... 2014  That,s Nice LLC, a research-focused strategic marketing ... formation of a new dedicated team that will support ... will combine current and new staff in both market ... Guy Tiene has been hired ... Tiene was previously Director of Marketing for Royal DSM,s ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3
... Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates for central nervous system disorders, today announced ... December 31, 2008. Vanda reported a net loss ... compared to $10.9 million for the third quarter of ...
... Development Conference features presentations from industry and academic speakers who ... and chemical industries. Topics include Chemical and Process R&D, ... by Design (QbD). , ... Columbia, ...
... New Mexico, February 10, 2009A team of Los Alamos ... multiplicationwhen a photon creates multiple electronsis a real phenomenon ... born of extraneous effects that mimic carrier multiplication. The ... of Chemical Research , shows the possibility of solar ...
Cached Biology Technology:Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 2Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 3Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 4Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 5Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 6Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 7Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 8Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 9Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 1016th International Process Development Conference to be Held June 14-17, 2009 in Arosa, Switzerland 2Research highlights potential for improved solar cells 2Research highlights potential for improved solar cells 3
(Date:8/26/2014)... New Zealand endemic tree has for the last 31 years ... Australian shrubs and small trees. A New Zealand botanist has ... astonishing cryptic diversity behind what was long considered a single ... journal PhytoKeys . , Known to botanists ... the many discoveries made in the north-western South Island of ...
(Date:8/26/2014)... assistant professor of mathematical sciences at New Jersey Institute ... into the biological clock that sets the pace for ... humans and all other mammals with fundamental rhythms of ... experienced each day and with seasonal change. The brain,s ... of sleep/wake behavior which, when disrupted by experiences such ...
(Date:8/26/2014)... social problems such as global warming and poverty ... the burden fall on our failure as consumers ... new study in the Journal of Consumer ... solving global problems from governments to consumers and ... businesses convince politicians to encourage responsible consumption instead ...
Breaking Biology News(10 mins):And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 2And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 3Researching fundamental rhythms of life 2Researching fundamental rhythms of life 3An inconvenient truth: Does responsible consumption benefit corporations more than society? 2
... energy or one that,s environmentally destructive? That,s the question ... Society Forum session on fracking April 10, 2013 from 3 ... NJIT Technology and Society Forum is free and open to ... underground at high pressure to fracture rock formations in order ...
... yet available to build a comprehensive map of the activity ... world the human brain, scientists say in a newly ... and developed for the Brain Activity Mapping (BAM) Project, which ... Project did for genetics. Published in the journal ...
... prey, most of us picture stealthy lions and restless gazelle, ... But Ben Baiser, a post-doctoral fellow at the Harvard Forest ... , thinks on a more local scale. His inter-species drama ... North America, home to the carnivorous pitcher plant, Sarracenia ...
Cached Biology News:Fracking: Challenges and opportunities 2Brain Activity Mapping Project aims to understand the brain 2An inside look at carnivorous plants 2
NATIVE RAT OSTEOCALCIN...
Form: Ready to use Applications: ELISA...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Wnt-1 (G-19)...
Biology Products: